Tumor hypoxia, p53, and prognosis in cervical cancers

International Journal of Radiation Oncology Biology Physics

Volumn 50, Issue 4, 2001, Pages 865-872

  Haensgen, Gabriele ^a   Krause, Ulf ^a   Becker, Axel ^b   Stadler, Peter ^b   Lautenschlaeger, Christine ^a   Wohlrab, Wolfgang ^a   Rath, Friedrich W ^a   Molls, Michael ^b   Dunst, Juergen ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Anemia; Cervical cancer; Hypoxia; p53; Prognosis

Indexed keywords

ANTIBODIES; BIOPSY; CELLS; DEGRADATION; PROTEINS; VIRUSES;

CERVICAL CANCERS; HYPOXIA;

TUMORS;

HEMOGLOBIN; PROTEIN P53;

ADULT; AGED; ANEMIA; ARTICLE; CANCER SURVIVAL; FEMALE; FLOW CYTOMETRY; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOLOGY; MAJOR CLINICAL STUDY; OXYGENATION; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 0035879413     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01523-1     Document Type: Article

References (42)

1. Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma
2. Cancer therapy and tumor physiology
3. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors
4. The p53 gene as a modifier of intrinsic radiosensitivity; Implications for radiotherapy
5. Frequency of p53 codon 72 genotypes in human papillomavirus associated squamous intraepithelial lesions and cervical cancer
6. Expression of ras, c-myc, and p53 proteins in cervical intraepithelial neoplasia
7. p53 expression in carcinoma of the cervix
8. Human papillomavirus 18 oncoproteins E6 and E7 enhance irradiation- and chemotherapeutic agent-induced apoptosis in p53 and Rb mutated cervical cancer cell lines
9. Hypoxic cervical cancers with low apoptotic index are highly aggressive
10. Intratumor pO2, S-phase fraction and p53 status in cervix carcinomas
11. bcl-2 immunoreactivity but not p53 accumulation associated with tumor response to radiotherapy in cervical carcinoma
12. Immunohistochemical detection of p53 and bcl-2 proteins in neoplasie and non-neoplastic endocervical glandular lesions
13. Activating mutations for transformation by p53 produce a gene product that forms an hsc-70-p53 complex with an altered half-life
14. The role of DNA index as a prognostic factor in early cervical carcinoma
15. DNA content as prognostic factor in cervix carcinoma stage IB-III treated with radiotherapy
16. High-dose-rate afterloading brachytherapy in carcinoma of the cervix; An experience of 1992 patients
17. Non-uniform dwell times in line source high dose rate brachytherapy; Physical and radiobiological considerations
18. An audit of the treatment of carcinoma of the uterine cervix using external beam radiotherapy and a single line source brachytherapy technique
19. Radiotherapy and anaemia-the clinical experience
20. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix
21. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix
22. Intratumoral pO2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix
23. Cervix cancer oxygenation measured following external radiation therapy
24. Pretreatment apoptosis in carcinoma of the cervix correlates with changes in tumor oxygenation during radiotherapy
25. Oxygenation of squamous cell carcinoma of the head and neck; Comparison of primary tumors, neck node metastases, and normal tissue
26. tp53 dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest
27. Expression of ras, c-myc, and p53 proteins in cervical intraepithelial neoplasia
28. Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas
29. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer
30. Growth inhibition of cervical tumor cells by antisense oligodeoxynucleotides directed to the human papillomavirus type 16 E6 gene
31. Different profiles of allelic losses in cervical carcinoma cases in Surinam and The Netherlands
32. A p53 and apoptotic independent role for p21waf1 in tumor response to radiation therapy
33. Prognostic significance of Bcl-2 and p53 protein expression in stage IIB and IIIB squamous cell carcinoma of the cervix
34. Prognostic significance of immunohistochemically detected p53 protein expression in stage IIIB squamous cell carcinoma of the uterine cervix treated with radiation therapy alone
35. Oncogene expression and microvessel count in recurrent and nonrecurrent stage Ib squamous cell carcinoma of the cervix
36. Hypoxia-induced apoptosis in human cells with normal p53 status and function, without any alteration in the nuclear protein level
37. Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen condition